Cepheid's Xpert® HCV: Results you can trust
Underdiagnosis of hepatitis C remains one of the most significant barriers to HCV elimination and public health since only 49%–55% of people with chronic HCV disease are aware of their infection status.*
Through proven scientific expertise and innovative test design, Cepheid now delivers the game-changing Xpert HCV, the first-ever CLIA waived hepatitis C RNA test in the U.S., supporting a robust elimination plan for hepatitis C. With Cepheid's Xpert HCV, patients can undergo testing, receive a diagnosis, and seamlessly connect to treatment and care in a single visit. This efficient process has the potential to save time and ensure more patients stay in care, leading to more people being cured of hepatitis C.
Xpert HCV is a CLIA waived test that allows you to:
- Collect and test fingerstick blood at the point of care (POC)
- Detect HCV acute and chronic infections in as little as 41 minutes
- Reduce the risk of loss to follow-up*#
- Save time and resources with immediate on-site confirmatory results versus sending out tests*#
Benefits of Xpert HCV
Xpert HCV is designed to provide trusted results that healthcare providers can rely on. The test's rapid turnaround time allows for same-day testing and treatment, enabling prompt diagnosis and immediate treatment options. This is crucial in managing hepatitis C effectively and preventing the spread of the virus.
The test-and-treat approach facilitated by Xpert HCV simplifies the healthcare process, making it easier for providers to deliver comprehensive care. The definitive Hep C RNA results provided by Xpert HCV from fingerstick blood samples ensure accurate and reliable detection, which is essential for effective patient management.
Connect with an associate to transform your diagnostic pathway!
Speak with an expert on our team.
"Rapid HCV RNA tests, which detect HCV genetic material, offer the greatest advantage for diagnosis and rapid initiation of treatment as the presence of HCV RNA confirms current infection.†"
Take Action Now
Contact us today to learn more about how Cepheid Xpert HCV can enhance your hepatitis C testing and treatment capabilities.
US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
* Page and Feinberg. What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting?JID 2024,
https://doi.org/10.1093/infdis/jiad269
^ with EAT earliest time for positives is 41 minutes.
# Applegate TL, Fajardo E, Sacks JA. Hepatitis C Virus Diagnosis and the Holy Grail. Infect Dis Clin North Am. 2018;32(2):425-445. doi:10.1016/j.idc.2018.02.010
† Grebely J, Applegate TL, Cunningham P, Feld JJ. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis. Expert Rev Mol Diagn 2017; 17:1109–15.
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.
For more information, visit www.cepheid.com
904 Caribbean Drive, Sunnyvale, CA 94089
©2025 Cepheid. All Rights Reserved.